An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond.
- DOI
- 10.3390/vaccines14090736
- Published
- 2026 Aug 26
- Container
- Vaccines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/vaccines14090736,
title = {An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond.},
author = {McIntyre P and van den Biggelaar AHJ and Beard F and Nowlan M and Regan AK and Pearce R and Nolan T and Hughes C and Richmond P},
year = {2026},
journal = {Vaccines},
doi = {10.3390/vaccines14090736},
url = {https://doi.org/10.3390/vaccines14090736}
}RIS
TY - JOUR TI - An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond. AU - McIntyre P AU - van den Biggelaar AHJ AU - Beard F AU - Nowlan M AU - Regan AK AU - Pearce R AU - Nolan T AU - Hughes C AU - Richmond P PY - 2026 JO - Vaccines DO - 10.3390/vaccines14090736 UR - https://doi.org/10.3390/vaccines14090736 ER -
APA
P, M., AHJ, V. D. B., F, B., M, N., AK, R., R, P., T, N., C, H., & P, R. (2026). An Expert Perspective on a New Recombinant Pertussis-Only Vaccine and Its Potential Clinical and Programmatic Advantages in Australia, New Zealand, and Beyond.. Vaccines. https://doi.org/10.3390/vaccines14090736
Source records
- pubmed · retrieved 2026-09-26T17:34:48.039Z